All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML

The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What is the outcome of transplantation in fit patients over 64 years?

During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Gabriele Magliano, Università Cattolica del Sacro Cuore, Rome, IT. We asked, What is the outcome of transplantation in fit patients over 64 years?

What is the outcome of transplantation in fit patients over 64 years?

In this video, Magliano discusses allogeneic hematopoietic stem cell transplantation outcomes for fit patients with AML over the age of 64. He explains that nowadays, age is not the main factor influencing whether patients achieve complete remission, but rather their overall clinical presentation. Magliano outlines the results of recent cohort trials on geriatric patients with AML and remains hopeful for future therapies.

 

Share:
More about...